Contact this trialFirst, we need to learn more about you.
PointCheck for Low White Blood Cell Count
Recruiting1 award5 criteria
Boston, Massachusetts
This trial will help assess a new technology, PointCheck, for monitoring chemotherapy-induced neutropenia. The study will include 90 patients with cancer, who will use the technology twice during a session, and in an at-home setting. The trial will evaluate the usability of PointCheck and its accuracy and precision.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service